Pathogenesis of Pulmonary Hemorrhagic Syndrome in Human Leptospirosis.
Nicodemo AC, Duarte-Neto AN.
Am J Trop Med Hyg. 2021 Apr 19;104(6):1970-1972. doi: 10.4269/ajtmh.20-1000.
PMID:33872210
Leptospirosis: clinical aspects.
Rajapakse S.
Clin Med (Lond). 2022 Jan;22(1):14-17. doi: 10.7861/clinmed.2021-0784.
PMID:35078790
Leptospirosis in humans.
Haake DA, Levett PN.
Curr Top Microbiol Immunol. 2015;387:65-97. doi: 10.1007/978-3-662-45059-8_5.
PMID:25388133
Leptospirosis manifested with severe pulmonary hemorrhagic syndrome successfully treated with veno-venous extracorporeal membrane oxygenation: A case report and literature review.
Zhang XC, Lei XQ, Sun Y, Shan NB.
Medicine (Baltimore). 2024 Dec 20;103(51):e40942. doi: 10.1097/MD.0000000000040942.
PMID:39705464
The emergence of severe pulmonary hemorrhagic leptospirosis: questions to consider.
Truong KN, Coburn J.
Front Cell Infect Microbiol. 2012 Jan 6;1:24. doi: 10.3389/fcimb.2011.00024. eCollection 2011.
PMID:22919589
Leptospirosis: a zoonotic disease of global importance.
Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM; Peru-United States Leptospirosis Consortium.